Chronic treatment with the mGlu5R antago
✍
Maria Rosaria Domenici; Rosa Luisa Potenza; Alberto Martire; Roberto Coccurello;
📂
Article
📅
2005
🏛
John Wiley and Sons
🌐
English
⚖ 219 KB
## Abstract This study was designed to test whether chronic treatment with the metabotropic glutamate receptor 5 (mGlu5R) antagonist MPEP showed antiparkinsonian effects in rats unilaterally lesioned with 6‐hydroxydopamine (6‐OHDA) (a “classic” model of Parkinson's disease, PD), and to evaluate whe